Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions

R. David Anderson, E. Magnus Ohman, David Holmes, Robert A. Harrington, Gregory W. Barsness, Nancy M. Wildermann, Harry R. Phillips, Eric J. Topol, Robert M. Califf

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Objectives. We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions. Background. Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown. Methods. Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment. Results. The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2% vs. <1%, p = 0.002 at 30 days, 5% vs. 1%, p = 0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p = 0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95% confidence interval 1.1 to 3.5). Conclusions. A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.

Original languageEnglish (US)
Pages (from-to)936-941
Number of pages6
JournalJournal of the American College of Cardiology
Volume32
Issue number4
DOIs
StatePublished - Oct 1 1998

Fingerprint

Percutaneous Coronary Intervention
Heart Failure
Left Ventricular Function
Mortality
Angioplasty
Coronary Artery Disease
Logistic Models
History
Myocardial Infarction
Databases
Confidence Intervals
Physicians

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. / Anderson, R. David; Ohman, E. Magnus; Holmes, David; Harrington, Robert A.; Barsness, Gregory W.; Wildermann, Nancy M.; Phillips, Harry R.; Topol, Eric J.; Califf, Robert M.

In: Journal of the American College of Cardiology, Vol. 32, No. 4, 01.10.1998, p. 936-941.

Research output: Contribution to journalArticle

Anderson, RD, Ohman, EM, Holmes, D, Harrington, RA, Barsness, GW, Wildermann, NM, Phillips, HR, Topol, EJ & Califf, RM 1998, 'Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions', Journal of the American College of Cardiology, vol. 32, no. 4, pp. 936-941. https://doi.org/10.1016/S0735-1097(98)00339-8
Anderson, R. David ; Ohman, E. Magnus ; Holmes, David ; Harrington, Robert A. ; Barsness, Gregory W. ; Wildermann, Nancy M. ; Phillips, Harry R. ; Topol, Eric J. ; Califf, Robert M. / Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions. In: Journal of the American College of Cardiology. 1998 ; Vol. 32, No. 4. pp. 936-941.
@article{2ff2a78281a24586a425d767c742281c,
title = "Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions",
abstract = "Objectives. We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions. Background. Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown. Methods. Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment. Results. The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2{\%} vs. <1{\%}, p = 0.002 at 30 days, 5{\%} vs. 1{\%}, p = 0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p = 0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95{\%} confidence interval 1.1 to 3.5). Conclusions. A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.",
author = "Anderson, {R. David} and Ohman, {E. Magnus} and David Holmes and Harrington, {Robert A.} and Barsness, {Gregory W.} and Wildermann, {Nancy M.} and Phillips, {Harry R.} and Topol, {Eric J.} and Califf, {Robert M.}",
year = "1998",
month = "10",
day = "1",
doi = "10.1016/S0735-1097(98)00339-8",
language = "English (US)",
volume = "32",
pages = "936--941",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions

AU - Anderson, R. David

AU - Ohman, E. Magnus

AU - Holmes, David

AU - Harrington, Robert A.

AU - Barsness, Gregory W.

AU - Wildermann, Nancy M.

AU - Phillips, Harry R.

AU - Topol, Eric J.

AU - Califf, Robert M.

PY - 1998/10/1

Y1 - 1998/10/1

N2 - Objectives. We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions. Background. Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown. Methods. Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment. Results. The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2% vs. <1%, p = 0.002 at 30 days, 5% vs. 1%, p = 0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p = 0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95% confidence interval 1.1 to 3.5). Conclusions. A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.

AB - Objectives. We sought to determine the prognostic significance of a history of congestive heart failure above that provided by baseline ejection fraction in patients undergoing percutaneous coronary interventions. Background. Left ventricular function is a known predictor of survival in patients with coronary artery disease, as is a history of congestive heart failure. The contribution of heart failure history independent of left ventricular function is unknown. Methods. Data were pooled from four interventional trials and the Duke University database. The combined dataset included 5,260 patients undergoing percutaneous interventions, 334 with and 4,926 without a history of heart failure. Patients were defined by the treating physician as having a clinical history of heart failure at the time of enrollment. Results. The 30-day and 6-month mortality were higher in patients with a clinical history of congestive heart failure than in those without such a history (2% vs. <1%, p = 0.002 at 30 days, 5% vs. 1%, p = 0.001 at 6 months). Heart failure history did not influence the incidence of myocardial infarction, use of angioplasty or the use of bypass surgery during follow-up. Multivariable analysis revealed that heart failure history added significantly to ejection fraction in predicting intermediate-term (6-month) mortality (p = 0.01). Stepwise logistic regression also revealed heart failure history to be an independent predictor of 6-month mortality (odds risk 1.9, 95% confidence interval 1.1 to 3.5). Conclusions. A clinical history of congestive heart failure is associated with increased early and intermediate-term mortality in patients undergoing percutaneous revascularization. Congestive heart failure history appears to provide prognostic information independent of that available from a patient's left ventricular function. These findings suggest that patients with a clinical history of congestive heart failure who undergo a percutaneous intervention should be closely monitored, especially those with the lowest ejection fractions.

UR - http://www.scopus.com/inward/record.url?scp=0032192129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032192129&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(98)00339-8

DO - 10.1016/S0735-1097(98)00339-8

M3 - Article

C2 - 9768714

AN - SCOPUS:0032192129

VL - 32

SP - 936

EP - 941

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 4

ER -